Skip to content
MedsAcross

Manufacturer

Kyowa Kirin

Pharmaceutical manufacturer based in Japan
Japan
Products listed
7
Molecules
4
Therapy areas
3

Kyowa Kirin is a pharmaceutical manufacturer based in Japan. MedsAcross lists 7 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country
Japan
Indian manufacturer
No
Also listed as
Kyowa Kirin, Inc.
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Kyowa Kirin products through licensed channels, with the documents your regulator needs.

Bone health

3 presentations

Bone health overview
MedicineActive ingredientRegisterAvailability
Crysvita 10 mg/1 mL injectionSubcutaneous Cold chainBurosumabUS FDAAvailable on request
Crysvita 20 mg/1 mL injectionSubcutaneous Cold chainBurosumabUS FDAAvailable on request
Crysvita 30 mg/1 mL injectionSubcutaneous Cold chainBurosumabUS FDAAvailable on request

Oncology

2 presentations

Oncology overview
MedicineActive ingredientRegisterAvailability
Fareston 60 mg tabletOralToremifeneUS FDAAvailable on request
Poteligeo 20 mg/5 mL injectionIntravenous Cold chainMogamulizumabUS FDAAvailable on request

Neurology

2 presentations

Neurology overview
MedicineActive ingredientRegisterAvailability
Nourianz 20 mg tabletOralIstradefyllineUS FDAAvailable on request
Nourianz 40 mg tabletOralIstradefyllineUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Kyowa Kirin

Send a request for any of these products. We confirm the licensed source, documents and lead time.